Tumor suppressor functions for GPER1 came from studies that showed decreased GPER1 expression levels in CRC patients and colorectal adenoma tissues, which correlated with increased tumor progression, lymph node metastasis, and decreased survival rates (66). The gene discussed is GPER1; the disease is neoplasm.